This trial is testing whether the medication Levocetirizine can help improve asthma control in children who have uncontrolled persistent allergic asthma, and who are either hyperresponsive or hyporesponsive to histamine. The trial will compare results between African American/Black and Caucasian/White children.
- Asthma, Allergic
1 Primary · 2 Secondary · Reporting Duration: 6 weeks
2 Treatment Groups
1 of 2
1 of 2
300 Total Participants · 2 Treatment Groups
Primary Treatment: Levocetirizine (LTZ) · Has Placebo Group · Phase 3
Who is running the clinical trial?
Age 6 - 17 · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many people are meeting the requirements for this clinical trial?
"Yes, the trial is still recruiting patients. According to the information on clinicaltrials.gov, this study was first posted on 4/28/2021 and was last updated on 4/26/2022. They are looking for 300 patients from 1 site." - Anonymous Online Contributor
How do I sign up for this test?
"This trial is looking for 300 participants with asthma and allergies between the ages of 6 and 17. The most important criteria for candidates are as follows: A diagnosis of asthma from a physician, uncontrolled asthma based on Asthma Control Test (ACT) score in the last 3 months or at screening, evidence of allergic sensitization from allergy skin test or allergy blood test results, currently being treated with asthma guideline-based therapy, males and females 6 through 17 years old at time of enrollment, written permission/assent to participate, children who self-identify as African American/black or Caucasian/white." - Anonymous Online Contributor
Has the FDA given the okay to market Levocetirizine?
"Levocetirizine has been studied in multiple Phase 3 clinical trials, which provides evidence of both its efficacy and safety. Therefore, our team at Power rates the safety of Levocetirizine as a 3 on our scale." - Anonymous Online Contributor
Are there any other ongoing research projects that include Levocetirizine?
"At this time, there are 2 clinical trials underway for Levocetirizine (LTZ). 1 of those is currently in Phase 3. The majority of the research being conducted on Levocetirizine (LTZ) is based in Kansas City, Missouri; however, there is 1 other location running a trial for this medication." - Anonymous Online Contributor
Are participants in this trial of age 18 years or older?
"In order for a patient to be included in this trial, they must be aged between 6 and 17 years old. Out of the 327 similar studies, 119 are for patients under 18 and 204 are for patients over 65." - Anonymous Online Contributor
For what common ailment is Levocetirizine (LTZ) most often prescribed?
"Levocetirizine is most commonly used to treat seasonal allergies, but it can also alleviate conditions like catarrh, chronic idiopathic urticaria, and nasal congestion." - Anonymous Online Contributor
Are people still being signed up for this experiment?
"Yes, this information is accurate. The study was posted on April 28th, 2021 and updated on April 26th, 2022." - Anonymous Online Contributor
What other similar medical trials have preceded this one?
"Clinical research for Levocetirizine (LTZ) started in 2009. The first large-scale study was sponsored by HK inno.N Corporation and had 100 participants. After the success of the initial Phase 4 trial, there are now 2 active studies being conducted across 1 city and 1 nation." - Anonymous Online Contributor